Project Grant K43TW011095

This Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) supports research to develop Kaposi's sarcoma-associated herpesvirus (KSHV)-infected lymphatic endothelial cell-based models of Kaposi's sarcoma (KS). The $411,400 award to Northwestern University aims to identify KSHV-induced cellular genes that promote the loss of contact inhibition of proliferation, a hallmark of oncogenic transformation, in KSHV-infected lymphatic endothelial cells (KLECs)....

This Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) provides funding for a research project focused on the Kaposi's sarcoma-associated herpesvirus (KSHV) and its role in the development of three AIDS-associated malignancies: Kaposi sarcoma, a plasmablastic variant of multicentric Castleman disease, and primary effusion lymphoma. The $564,698 award, which runs from January 1, 2025 to December 31, 2029, will support studies to better...

This Project Grant from the U.S. Department of State Bureau of African Affairs provided $120,179.59 to Ciheb Zambia LIMITED for community-led monitoring to improve the quality of HIV care in Zambia through client feedback. The grant was awarded on April 1, 2021 with a completion date of January 31, 2022. Under the President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029), the grantee and three sub-awardees—Ndekeleni Development Foundation, Youth Development Organisation, and...

The Department of State Bureau of African Affairs awarded a $110,000 project grant to Treatment Advocacy And Litera CY Campaign to implement the COMMUNITY LED MONITORING TO IMPROVE QUALITY OF HIV CARE IN ZAMBIA THROUGH CLIENT FEEDBACK project from March 1, 2022 to December 30, 2022. Under this award, Treatment Advocacy And Litera CY Campaign will work to improve HIV care quality in Zambia by establishing a community-led monitoring program that gathers client feedback. The grant is part of the...

This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $188,169 to the University of California, Davis to conduct proof-of-concept studies evaluating a novel gene therapy approach for treating Kaposi's Sarcoma-associated Herpesvirus (KSHV)-related cancers. The project aims to develop an adeno-associated virus (AAV) vector that selectively expresses a therapeutic gene in KSHV-infected tumor cells, using the KSHV latency-associated nuclear...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $381,487 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Maryland, Baltimore (UMB) to assess the implementation and outcomes of introducing long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women at high risk of HIV acquisition in Zambia. The study, titled "Scaling Comprehensively Access to Long-Acting for...

This $1,325,208 Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) supports a research study in Zambia to evaluate sequential strategies for returning individuals with HIV care lapses to treatment and keeping them re-engaged long-term. The prime awardee is Washington University, which is partnering with the Centre for Infectious Disease Research in Zambia (CIDRZ) and Seoul National University to implement the study. The project aims...

This Cooperative Agreement award from the U.S. Department of State's Bureau of African Affairs, provided under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program (CFDA 19.029), supports a community-led monitoring initiative to improve the quality of HIV care services in Zambia. The $104,988 award, granted on March 18, 2024, will enable the recipient organization, Family Development Initiatives LIMITED, to train local community members to collect client feedback on...

The Luapula Foundation will provide $110,000 in community-led monitoring services to improve HIV care quality in Zambia through client feedback under a FY22 Project Grant from the U.S. Department of State Bureau of African Affairs. Funded through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029), the grant will support monitoring activities from March 1, 2022 through December 30, 2022. PEPFAR coordinates the U.S. global response to HIV/AIDS. This award will...

The Luapula Foundation received a $124,016.05 Project Grant award from the U.S. Department of State Bureau of African Affairs to implement the "COMMUNITY LED MONITORING TO IMPROVE QUALITY OF HIV CARE IN ZAMBIA THROUGH CLIENT FEEDBACK" program. The grant period runs from April 1, 2021 through January 31, 2022. The program will utilize community-led monitoring to improve the quality of HIV care in Zambia through client feedback. Specifically, the Luapula Foundation will work directly...